BioCentury
ARTICLE | Company News

Bayer, Inverness sales and marketing update

December 5, 2005 8:00 AM UTC

BAYG's Bayer Diagnostics division received an option to commercialize worldwide IMA's Urotensin marker for congestive heart failure (CHF) on Bayer's automated immunoassay systems. The companies also p...